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Yessotoxin (YTX) modulates cellular phosphodiesterases (PDEs). In this regard, opposite
effects had been described in the tumor model K-562 cell line and fresh human
lymphocytes in terms of cell viability, cyclic adenosine 3’,5’-cyclic monophosphate
(cAMP) production and protein expression after YTX treatment. Studies in depth of the
pathways activated by YTX in K-562 cell line, have demonstrated the activation of two
different cell death types, apoptosis, and autophagy after 24 and 48 h of treatment,
respectively. Furthermore, the key role of type 4A PDE (PDE4A) in both pathways
activated by YTX was demonstrated. Therefore, taking into account the differences
between cellular lines and fresh cells, a study of cell death pathways activated by YTX in
a non-tumor cell line with mitotic activity, was performed. The cellular model used was
the lymphoblastoid cell line that represents a non-tumor model with normal apoptotic
and mitotic machinery. In this context, cell viability and cell proliferation, expression of
proteins involved in cell death activated by YTX and mitochondrial mass, were studied
after the incubation with the toxin. Opposite to the tumor model, no cell death activation
was observed in lymphoblastoid cell line in the presence of YTX. In this sense, variations
in apoptosis hallmarks were not detected in the lymphoblastoid cell line after YTX
incubation, whereas this type I of programmed cell death was observed in K-562 cells.
On the other hand, autophagy cell death was triggered in this cellular line, while other
autophagic process is suggested in lymphoblastoid cells. These YTX effects are related
to PDE4A in both cellular lines. In addition, while cell death is triggered in K-562 cells
after YTX treatment, in lymphoblastoid cells the toxin stops cellular proliferation. These
results point to YTX as a specific toxic compound of tumor cells, since in the non-tumor
lymphoblastoid cell line, no cell death hallmarks are observed.
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Introduction
Under unfavorable conditions, cells develop different strategies to survive and autophagy is
the main mechanism; if survival is not possible, they activate autophagy cell death (Codogno
and Meijer, 2005). Autophagy, also known as type II programmed cell death is activated after
nutrient deprivation or with other stimulus, such as rapamycin treatment (Jung et al., 2010;
Ouyang et al., 2012). In both cases, the target is the protein mTOR. This protein inhibits the
autophagy through its active phosphorylated form (pmTOR). Under unfavorable conditions, the
protein is dephosphorylated and inactivated, and as a result the autophagy cascade is triggered
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(Jung et al., 2010). Then, a complex network of metabolic
pathways is activated to develop digestive vacuoles, called
autophagosomes. These vacuoles are covered by type II of Light
Chain 3 (LC3-II) protein (Codogno and Meijer, 2005; Stern
et al., 2012). Three different human isoforms are described of
LC3 protein: LC3A, LC3B, and LC3C (Wu et al., 2006). These
types of LC3 protein are synthesized as the cytosolic type I LC3
protein (LC3A-I, LC3B-I, or LC3C-I) under normal conditions.
When autophagy is activated, LC3-I is metabolized in type II
(LC3A-II, LC3B-II, or LC3C-II) that binds to autophagosomes
membrane (Lazova et al., 2012). Different parts of the cell
and damaged organelles are digested by autophagosomes and
fused with lysosomes (Klionsky and Emr, 2000). In this way,
the basic elements to survive under unfavorable conditions are
obtained (Cuervo et al., 2005). However, sometimes, autophagy
degenerates in the digestion of the whole cell leading to the
autophagy cell death (Tsujimoto and Shimizu, 2005). Another
type of programmed cell death is apoptosis, also known
as the type I of programmed cell death (Ouyang et al.,
2012). Apoptosis can be activated through the intrinsic or
mitochondrial apoptotic cell death or through the extrinsic or
death receptor (DR) pathway (Elmore, 2007). The first one,
known as mitochondrial apoptosis, is triggered by different
stimulus that destabilizes mitochondrial membrane potential. As
a result, the mitochondrial permeability transition pore (MPTP)
is opened and pro-apoptotic proteins are released from the
intermembrane space to the cytosol (Debatin et al., 2002). The
pro-apoptotic proteins such as cytochrome c, smac/DIABLO,
apoptotic inductor factor (AIF), and endonuclease G, activate
first caspase 9 and then caspase 3 along with the rest of the
apoptotic pathway (Javadov and Karmazyn, 2007). The extrinsic
apoptotic cell death is triggered after the binding of a ligand to
the DR that belongs to the tumor necrosis factor receptor family
(TNFR), in the plasmatic membrane. Then, the death inducing
signaling complex (DISC) is developed in the cytosolic region
of the plasma membrane. This complex recruits and cleaves
procaspases 8 and 10 into the active forms caspases 8 and 10.
Caspase 8 also activates caspase 3 and converges at this point with
the intrinsic apoptotic pathway (Korsnes and Espenes, 2011).
Yessotoxins (YTXs) are sulfated polyether compounds
isolated for the first time from the scallops Patinopecten yessoensis
(Murata et al., 1987). However, this group of toxins are
synthesized by the dinoflagellates Protoceratium reticulatum,
Lingulodinium polyedrum, and Gonyaulax spinifera (Satake et al.,
1997; Paz et al., 2004; Rhodes et al., 2006). YTXs are modulators
of phosphodiesterases (PDEs) and consequently affect the levels
of cyclic adenosine 3′,5′-cyclic monophosphate (cAMP) (Alfonso
et al., 2003, 2004, 2005; Pazos et al., 2006). The final effect is
different depending on the cellular model studied, human fresh
lymphocytes or human leukemic K-562 cell line (Alfonso et al.,
2003; Tobío et al., 2012). Moreover, YTX has been described
as a mitochondrial apoptosis inducer (Korsnes and Espenes,
2011; Korsnes, 2012). On the other hand, the structural protein
A kinase anchoring protein 149 (AKAP149) binds PDE4A and
protein kinase A (PKA) to the outer mitochondrial membrane
(Asirvatham et al., 2004; Carlucci et al., 2008). These three
components make a complex that is regulated by cAMP levels,
since this second messenger activates PKA, and the whole
complex moves around the cell depending on cAMP gradients
(Baillie et al., 2005; Sample et al., 2012). Since YTX modulates
PDEs, the complex was studied after toxin treatment in the tumor
K-562 cell line. In this sense, a close relation between the complex
expression and cell death activated by the toxin was discovered
(Tobío et al., 2012; Fernandez-Araujo et al., 2014). This was
supported by the fact that silencing the expression of PDE4A, the
effect of YTX on K-562 cell viability is avoided and changes in
the cytosolic expression of the rest of the proteins of the complex
is observed (Fernandez-Araujo et al., 2014). In addition, a key
role of PDE4A in apoptosis and autophagy cell death activated
by YTX in the K-562 cell line has been observed (Fernández-
Araujo et al., 2015). As mentioned, large differences, in terms of
YTX toxicity, cAMP levels and AKAP149 expression, were found
depending on the cellular model studied. In this sense, while no
effect on cell viability was observed in human fresh lymphocytes,
high cell death was detected in leukemic K-562 cells after YTX
treatment (Tobío et al., 2012). Later on, the effect in the K-562
line was studied in depth and YTXwas described as apoptotic and
autophagy inductor in these cells (Fernandez-Araujo et al., 2014).
As fresh lymphocytes have no mitotic capacity while leukemia
cells are tumor cells, the aim of this work was to study the effect
of YTX in a non-tumor cellular model with mitotic and apoptotic
intact machinery in order to elucidate whether the toxic effects
of YTX are exclusively for tumor cells or if they depend on the
mitotic machinery. For this objective a non-tumor cell line, a
lymphoblastoid cell line, was chosen. This cell line is a result of
human B lymphocytes immortalized with the Epstein Barr virus,
hence without tumor features (Sugimoto et al., 2004; Sie et al.,
2009; Hussain and Mulherkar, 2012).
Materials and Methods
Reagents and Solutions
YTX was obtained from CIFGA Laboratories (Lugo, Spain).
Anti-β-tubulin I, Bovine serum albumin (BSA), CaCl2,
NaH2PO4, Trizma hydrochloride, Triton X-100, glycine,
trizma base, SDS (sodium dodecyl sulfate) and Tween R©20 were
from Sigma-Aldrich (Madrid, Spain). NaCl, MgSO4, NaHCO3,
and glucose were from Panreac (Barcelona, Spain). Anti-PDE4A
and anti-LC3B was from ABCAM (CA, USA). Anti-Histone
1, anti-β-Actin, anti-pmTOR, anti-caspase 8 (active form),
anti-cytochrome C, anti-rabbit IgG peroxidase conjugated, and
Polyvinylidene fluoride (PVDF) membrane was from Millipore
(Temecula, USA). Anti-Mouse IgG horseradish peroxidase-
linked species-specific whole antibody was purchased from GE
Healthcare (Barcelona, Spain).
Polyacrylamide gels and molecular weight marker Precision
Plus Protein™ Standards Kaleidoscope™ were purchased from
BioRad R© (Barcelona, Spain). Protease Inhibitor Complete
Tablets and Phosphatase Inhibitor Cocktail Tablets were from
Roche (Spain). Free calcium and magnesium PBS used in flow
cytometry assays was purchased from Gibco, Life Technologies
(UK).
Physiological saline solution composition was (in mM): Na+
142.3; K+ 5.94; Ca2+ 1; Mg2+ 1.2; Cl− 126.2; HCO−3 22.85;
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HPO2−4 1.2, SO
2−
4 1.2; glucose 1 g/L was added to the medium
giving an osmotic pressure of 290 ± 10 mOsm/kg of H2O and
pH was adjusted to 7.2 with HCl 0.1 N and CO2. PBS used to
wash the western blottingmembranes consisted of NaCl 137mM;
Na2HPO4 10.14mM; KH2PO4 1.76mM; KCl 2.68mM; pH was
adjusted to 7.2 with NaOH.
Cell Culture
K-562 cell line was purchased from the National Cancer Institute
(NCI’s, USA) and maintained in the Roswell Park Memorial
Institute 1640 (RPMI 1640) medium supplemented with 10%
fetal bovine serum (FBS) and 50 units/ml penicillin and 50µg/ml
streptomycin. All these reagents were from Gibco, Invitrogen
(Spain). Cells were growing at 37◦C in a humidified 5% CO2
atmosphere. Incubations with 30 nMYTXwere carried out under
these conditions of temperature, humidity and percentage of
CO2.
Lymphoblastoid cell line was obtained from the Banco
Nacional de ADN Carlos III (Spain). This cell line is a result of
human B lymphocytes immortalized with the Epstein Barr virus,
without tumor features and can be used for genetic or functional
studies since these cells preserve the genetic characteristics of
the lymphocyte B donor (Sugimoto et al., 2004; Sie et al.,
2009; Hussain and Mulherkar, 2012). Lymphoblastoid cell line
is maintained in the Roswell Park Memorial Institute 1640
(RPMI 1640)mediumwith HEPES and glutamine (from Biowest,
France), supplemented with 15% fetal bovine serum (FBS),
100 units/ml penicillin and 100µg/ml streptomycin. All these
reagents were fromGibco (Invitrogen, Spain). Cells were growing
at 37◦C in a humidified 5% CO2 atmosphere. Incubations
with 30 nM YTX were carried out under these conditions of
temperature, humidity, and percentage of CO2.
Subcellular Fractionation
3 × 106 cells per condition were incubated for 24 and 48 h with
and without 30 nM YTX and then centrifuged and washed with
saline solution. Cells were resuspended in lysis buffer with the
following composition: 50mM Tris-HCl, 150mM NaCl, 1mM
EDTA, 1% Triton X-100, 1X Complete Protease Inhibitor and
1X Phosphatase Inhibitor Cocktail. The extract was sonicated
and centrifuged (9300 g, 10min, 4◦C). The supernatant with
the cytosolic fraction was transferred to a new tube and stored
at−20◦C for protein quantification.
Western Blotting Analysis
Direct Detect Spectrometer from Millipore (Germany) was used
to know sample protein concentration and BSA was used
as protein standard. The electrophoresis run conditions were
200V for 35min. The cytosolic fraction was blotted to PVDF
membrane with reduced SDS-PAGE. To determine the protein
size and also to monitor the progress of the electrophoretic runs,
a Precision Plus ProteinTM Standards Kaleidoscope™molecular
weight marker was used. After blockage with 0.5% BSA the
membranes were incubated for 10min with anti-cytochrome C,
anti-PDE4A, anti-caspase 8, and anti-pmTOR, then were washed
three times with PBS and 0.1% Tween R©20 and incubated for
10min with secondary anti-mouse or anti-rabbit IgG horseradish
peroxidase-linked species-specific whole antibody. After three
washes, chemiluminescence was visualized with SuperSignal R©
West Pico (low intensity) or with SuperSignal R© West Femto
(high intensity) both from Pierce (ThermoScientific, USA) and
it was also used a Clarity Western ECL substrate (medium
intensity) from BioRad R©. The chemiluminiscent signal was
detected with the Diversity GeneSnap software and analyzed
by the Diversity 4 gel documentation and analysis system.
Relative protein expression was calculated in relation to β-
actin expression for each experiment in the cytosolic fraction.
Experiments were carried out at least three times by duplicate.
The purity of the subcellular fraction was tested by measuring
control proteins from the cytosol fraction: Histone 1 was the
negative control, as it is only present in the nuclear fraction and
β-tubulin was the positive control because it is located in the
cytosolic fraction.
Cell Viability
After the treatment with the toxin, 5 × 105 cells per condition,
cells were centrifuged (250 × g, 4min, 4◦C) and pellet and
supernatant were separated. The pellets were first washed with
saline solution and centrifuged (1100 × g, 5min, 4◦C), and then
re-suspended in saline solution with MTT (250µg/mL) (M2128,
Sigma) and incubated for cell viability (Tobío et al., 2012). The
supernatants were utilized to measure LDH release by using
the in vitro Toxicology Assay Kit (TOX7, Sigma) following the
commercial protocol.
Mitochondrial Mass
After the treatment with the toxin, cells were washed with saline
solution, centrifuged (1200 × g, 5min, 4◦C) and incubated with
200 nM MitoTracker R© Deep Reed FM (Invitrogen, USA) for
30min, at 37◦C in dark. Then the cells were washed and fixed
with 4% paraformaldehyde (PFA) for 20min at 4◦C. Next, the
cells were washed twice with PBS free of calcium and magnesium
and finally resuspended in 80µL PBS for flow cytometry. The
data were analyzed with the IDEAS 4.0 Cell Image Analysis
software. The assays were performed with 1 × 106 cells per
condition.
Cell Proliferation
Cell proliferation was measured by using three methods, the
Scepter™ Handheld automated cell counter (Millipore, Spain)
and two methods for total cellular protein determination,
Bradford (Bio-Rad protein Assay) and the Direct Detect™
Spectrometer (Millipore, Germany). The number of cells was
corrected in each experiment with the cell viability data by using
theMTT assay. After the treatment with 30 nMof YTX for 24 and
48 h, 6× 105 cells per condition, cells were centrifuged (600× g,
5min, 4◦C), and supernatants were eliminated. The pellets were
first washed with saline solution and centrifuged (600 × g,
5min, 4◦C), and then re-suspended in saline solution 250µL.
Hundred microliter of cellular suspension were used to count
the number of cells with the Scepter™ Handheld automated
cell counter. One hundred and fifty microliter were centrifuged,
diluted in 50µl of water and sonicated. Then, the concentration
of protein was determined both, by Bradford assay and Direct
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Detect™ (Millipore, Spain). A calibration curve of number of
cells (750,000 from 50,000) vs. concentration of protein was done
in each experiment and the linearity was always higher than 0.99
for both cellular lines.
Statistical Analysis
All the experiments were carried out at least three times by
duplicate. ANOVA was used to examine statistical significance,
assumed for p < 0.05. Results were expressed as the means ±
SEM.
Results
Opposite effects of YTX were reported in tumor K-562 cell
line and fresh human lymphocytes (Tobío et al., 2012). This
may be due to the differences between these cellular models,
since fresh human lymphocytes do not have the ability to grow
by themselves. Therefore, it would be interesting to compare
the effect of YTX in two cellular lines with similar mitotic
machinery. For this purpose, the lymphoblastoid cell line was
chosen as a non-tumor model, and compared with the K-562
tumor cell line model. The lymphoblastoid cell line can grow
and has normal apoptotic machinery, while the K-562 cell line
has not (Hussain and Mulherkar, 2012). Figure 1 shows cellular
proliferation, measured by MTT metabolization, and plasma
membrane integrity measured by LDH release (Figures 1A,B,
respectively) in both cell lines after 24 and 48 h of toxin exposure.
A 32% decrease in cell viability was observed in K-562 cell
line after 24 h with YTX. However, no effect was observed
in lymphoblastoid line under the same conditions. After 48 h
of treatment, K-562 cell viability was decreased by 59% while
the reduction in lymphoblastoid cell line was 27%. On the
other hand, after 24 h of YTX treatment, LDH release was 78%
increased in the K-562 cell line, while at this time YTX did not
induce any effect in LDH release in lymphoblastoid cells. After
48 h in the presence of YTX, the increase in LDH release was 52%
in K-562 cells, while no effects were observed in lymphoblastoid
cells.
The result obtained after 48 h of YTX treatment in
lymphoblastoid cells with MTT, show a decrease in cellular
proliferation but not in LDH release. Since the MTT dye is
metabolized by themitochondria, the fall ofMTT signal observed
may be caused either by a decrease in mitochondrial mass or
by a decrease in the cell number. To find out which of the two
options was going on, a dye to measure mitochondrial mass
was used and in this way to know the direct effect of YTX in
this organelle by using imaging flow cytometry. Therefore, in
Figure 2 mitochondrial mass is shown both in K-562 cell line
and in lymphoblastoid line. When the MitoTracker R©Deep Reed
FM dye is metabolized by the mitochondria, the intensity in
red channel is increased, therefore this signal is proportional
to mitochondria quantity. Figures 2A,B represent mitochondrial
mass of K-562 cells and lymphoblastoid cells, respectively, after
48 h of YTX incubation. Higher X-axis values represent more dye
intensity, hence more quantity of the mitochondria. Figure 2C
represents the mean of three experiments. This graphic shows a
significant 6% decrease of mitochondrial intensity after 48 h of
FIGURE 1 | Effect of YTX on cellular MTT signal and LDH release in
K-562 and lymphoblastoid cell lines. Cells were incubated with 30 nM YTX
for 24 and 48 h (37◦C and 5% CO2 atmosphere). (A) Percentage of cellular
proliferation measured by MTT assay in K-562 and lymphoblastoid cell lines
after 24 and 48 h of YTX incubation. (B) Percentage of LDH release of K-562
and lymphoblastoid cell lines after 24 and 48 h of YTX incubation. Mean ±
SEM of three experiments. *Significant differences between untreated and
YTX-treated cells in each case by ANOVA test.
incubation with YTX in a K-562 cell line, while the intensity is
9% increased in the lymphoblastoid line. Therefore, the decrease
in MTT signal obtained in Figure 1A with the lymphoblastoid
line after 48 h of treatment with YTX is probably not due to a
decrease in mitochondrial mass but probably due to a decrease in
the cell number with respect to the control without treatment.
It has been described the key role of PDE4A in the mechanism
of action of YTX (Fernandez-Araujo et al., 2014). Therefore,
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FIGURE 2 | Effect of YTX on total mitochondrial mass of K-562
and lymphoblastoid cell lines. Representative cellular images and
histograms of the mitochondrial mass intensities in K-562 and
lymphoblastoid cell lines after 48 h (A,B, respectively) of YTX incubation
(37◦C and 5% CO2 atmosphere). Brightfield images and red channel
images with MitoTracker®Deep Reed FM intensity are represented to
each cell model on the right of the histograms. (C) Percentage of cells
with mitochondrial mass intensities selected of K-562 and lymphoblastoid
cell lines after 48 h of YTX treatment. Data referred to untreated cells.
Mean ± SEM of three experiments (5000 cells were analyzed in each
experiment). *Significant differences between YTX-treated and untreated
cells by ANOVA test.
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this protein was studied in the lymphoblastoid cell line and
compared to the tumor K-562 cell line after YTX treatment.
Figure 3 shows the PDE4A expression in both cell models after
24 and 48 h (Figures 3A,D, respectively) of exposure to the toxin.
While a 25% decrease in PDE4A expression was observed in K-
562 cells after 24 h of treatment, no variations were detected in
the lymphoblastoid cell line (Figure 3A). However, as Figure 3D
shows, a decrease of 34 and 22%, in PDE4A levels was observed in
K-562 and lymphoblastoid lines, respectively, after 48 h of toxin
treatment. Therefore, cytosolic PDE4A levels are also involved
in YTX effect in lymphoblastoid cell line. Surprisingly, according
to the western blot experiments, different molecular weights for
PDE4A proteins were observed depending on cellular model
use. Figure 3G shows the PDE4A band with a lower molecular
weight, around 80 KDa, in the case of K-562 cells, and 98
KDa band in lymphoblastoid cells. This is the normal molecular
weight that targets the anti-PDE4A used in these experiments.
Either, the activation of both intrinsic and extrinsic apoptosis
processes through PDE4A modulation in K-562 cells after 24 h
YTX incubation, as well as the autophagy cell death triggered
through the PDE4A modulation in the same cell line after
48 h of YTX treatment were extensively studied (Fernandez-
Araujo et al., 2014; Fernández-Araujo et al., 2015). Therefore, the
activation of these pathways was checked in the lymphoblastoid
cell line. First, different apoptotic hallmarks were studied
under these conditions. Figure 4 shows the expression of the
mitochondrial apoptotic marker cytochrome c. While in the K-
562 cell line a 34% increase in cytosolic cytochrome c levels after
24 h YTX incubation, no effects were observed in lymphoblastoid
cells. The same happens when the typical extrinsic apoptotic
hallmark, the active form of caspase 8, was measured. As Figure 5
shows, caspase 8 levels were 75% increased in the tumor K-562
cell line in the presence of YTX for 24 h, while in these conditions
no effect was observed in the lymphoblastoid line. Therefore,
contrary to K-562 cell line, after 24 h of incubation in the presence
of YTX apoptosis was not activated in the lymphoblastoid cell
line. Since autophagy was trigged in the K-562 cell line after 48 h
of YTX incubation, next the active form of mTOR (pmTOR),
as one representative autophagy hallmark, was checked in the
lymphoblastoid cell line after 48 h incubation with the toxin
(Codogno and Meijer, 2005). Surprisingly, similar results were
obtained in both K-562 and lymphoblastoid cell lines. A decrease
of 39 and 40% was observed after 48 h of YTX treatment in the
tumor and in the non-tumor cell line, respectively (Figure 6).
Furthermore, Figure 7 shows the other autophagic hallmark
studied in both cell lines, the LC3B-II/LC3B-I ratio. Again very
similar results were obtained in both cellular models, since after
48 h of YTX incubation an increase of 208% in LC3B-II/LC3B-I
ratio was observed in K-562 cells and 190% in lymphoblastoid
cell line. Therefore, these results suggest the activation of an
autophagic pathway in the lymphoblastoid cell line, but it does
not imply the induction of cell death since no LDH release was
observed as Figure 1B shows. However, to confirm this theory,
the proliferation of both cell lines was studied, Figure 8. K-562
cells grow up from near to 6 × 105 cells at the beginning of the
experiment, time 0, to around 7.3× 105 after 24 h and to around
of 11 × 105 after 48 h (Figure 8A). However, after 24 h of YTX
FIGURE 3 | Effect of YTX on cytosolic PDE4A expression in K-562 and
lymphoblastoid cell. Cells were incubated for 24 and 48 h with 30 nM YTX
(37◦C and 5% CO2 atmosphere). (A,D) Percentage of cytosolic PDE4A levels
in K-562 and lymphoblastoid cell lines after 24 and 48 h of YTX incubation,
respectively. Mean ± SEM of three experiments. Cytosolic PDE4A values were
calculated respect to β-actin band intensity. 3× 106 cells per condition were
lysed and 20µg of total protein per condition was charged in the
electrophoresis gel. *Significant differences between untreated and
YTX-treated cells by ANOVA test. (B,C) Representative experiments of
western blot band intensity of cytosolic PDE4A in K-562 (∼80 KDa) and
lymphoblastoid (∼98 KDa) cell lines after 24 h of treatment, respectively. (E,F)
Representative experiments of western blot band intensity of cytosolic PDE4A
in K-562 (∼80 KDa) and lymphoblastoid (∼98 KDa) cell lines after 48 h of
treatment, respectively. (G) PDE4A band of K-562 and lymphoblastoid cell
lines in western blot membranes. PDE4A antibody targets to a PDE4A protein
with a molecular weight of 98 KDa.
incubation, the number of cells has decreased to 4.7 × 105 cells,
and after 48 h of YTX treatment, the number of cells has fallen
to near 3.7 × 105 cells. These results mean a decrease in cells
number after YTX incubation and significant differences were
obtained in untreated and YTX-treated cells. On the other hand,
lymphoblasoid cell line shows another pattern of proliferation
(Figure 8B). The total number of cells in control population was
around 5.6 × 105, 7.4 × 105, and 9 × 105 at time 0, after 24
and 48 h, respectively. However, after 24 h of YTX treatment,
the number of cells was near to 6.64 × 105, and after 48 h of
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FIGURE 4 | Effect of YTX on cytosolic cytochrome c expression in
K-562 and lymphoblastoid cell lines after 24h of incubation. Cells were
incubated for 24 h with 30 nM YTX (37◦C and 5% CO2 atmosphere). (A)
Percentage of cytosolic cytochrome c levels in K-562 and lymphoblastoid cell
lines after 24 h of YTX incubation. Mean ± SEM of three experiments.
Cytosolic cytochrome c values were calculated respect to β-actin band
intensity. 3× 106 cells per condition were lysed and 20µg of total protein per
condition was charged in the electrophoresis gel. *Significant differences
between untreated and YTX-treated cells by ANOVA test. (B,C) Representative
experiments of western blot band intensity of cytosolic cytochrome c in K-562
and lymphoblastoid cell lines after 24 h of treatment, respectively.
YTX incubation, the number of cells was around 5.5 × 105. No
significant differences in the number of cells were observed after
24 and 48 h of YTX treatment compared to time 0, therefore
neither cell death nor growth was detected. Also, no differences
were detected between untreated and YTX-treated cells after 24 h
of YTX incubation. However, the number of cells after 48 h of
YTX treatment was significantly lower compared to untreated
cells at this time. Therefore, the proliferation of lymphoblastoid
cell line was arrested by YTX effect.
Discussion
YTX activates different cell death types depending on the cellular
model (Korsnes, 2012). Moreover, opposite effects in terms of cell
viability were obtained after the treatment with YTX of the tumor
K-562 cell line and fresh human lymphocytes (Tobío et al., 2012).
These observations point to YTX as an interesting compound to
target tumor cell lines but not normal cells (Botana et al., 2011).
However, there are several differences between an immortalized
cellular line and fresh primary cells (Baserga, 1965). In this
context, the comparative study of YTX effect in a tumor cell
line and a non-tumor cell line could give interesting information
about the mechanism of action of YTX. The pathways activated
in the leukemic K-562 cell line by this toxin were widely studied.
It was described that PDE4A shows a key role in YTX effect that
leads to the activation of different programmed cell death types
(Tobío et al., 2012; Fernandez-Araujo et al., 2014; Fernández-
Araujo et al., 2015). The lymphoblastoid cell line used in this
paper is a result of human B lymphocytes immortalized with
the Epstein Barr virus, hence without tumor features and with
intact apoptotic and mitotic machineries (Sugimoto et al., 2004;
FIGURE 5 | Effect of YTX on cytosolic caspase 8 expression in K-562
and lymphoblastoid cell lines after 24h of incubation. Cells were
incubated for 24 h with 30 nM YTX (37◦C and 5% CO2 atmosphere). (A)
Percentage of cytosolic caspase 8 levels in K-562 and lymphoblastoid cell
lines after 24 h of YTX incubation. Mean ± SEM of three experiments.
Cytosolic caspase 8 values were calculated respect to β-actin band intensity.
3× 106 cells per condition were lysed and 20µg of total protein per condition
was charged in the electrophoresis gel. *Significant differences between
untreated and YTX-treated cells by ANOVA test. (B,C) Representative
experiments of western blot band intensity of cytosolic caspase 8 in K-562
and lymphoblastoid cell lines after 24 h of treatment, respectively.
FIGURE 6 | Effect of YTX on cytosolic pmTOR expression in K-562 and
lymphoblastoid cell lines after 48h of incubation. Cells were incubated
for 48 h with 30 nM YTX (37◦C and 5% CO2 atmosphere). (A) Percentage of
cytosolic pmTOR levels in K-562 and lymphoblastoid cell lines after 48 h of
YTX incubation. Mean ± SEM of three experiments. Cytosolic pmTOR values
were calculated respect to β-actin band intensity. 3× 106 cells per condition
were lysed and 20µg of total protein per condition was charged in the
electrophoresis gel. *Significant differences between untreated and
YTX-treated cells by ANOVA test. (B,C) Representative experiments of
western blot band intensity of cytosolic pmTOR in K-562 and lymphoblastoid
cell lines after 48 h of treatment, respectively.
Sie et al., 2009; Hussain and Mulherkar, 2012). Therefore, this
line is a good tool to study the effects of the toxin in a non-tumor
cellular model with mitotic ability to grow up (fresh cells do not
have this property), and normal apoptoticmachinery (tumor cells
do not have it) (Sugimoto et al., 2004; Sie et al., 2009; Hussain and
Mulherkar, 2012).
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FIGURE 7 | Effect of YTX on cytosolic LC3B-II/LC3B-I expression in
K-562 and lymphoblastoid cell lines after 48h of incubation. Cells were
incubated for 48 h with 30 nM YTX (37◦C and 5% CO2 atmosphere). (A)
Percentage of cytosolic LC3B-II/LC3B-I levels in K-562 and lymphoblastoid
cell lines after 48 h of YTX incubation. Mean ± SEM of three experiments.
Cytosolic LC3B-I and LC3B-II values were calculated respect to β-actin band
intensity and the ratio between LC3B-II and LC3B-I was calculated in order to
quantify the autophagosomal LC3B-II isotype 3× 106 cells per condition were
lysed and 20µg of total protein per condition was charged in the
electrophoresis gel. *Significant differences between untreated and
YTX-treated cells by ANOVA test. (B,C) Representative experiments of
western blot band intensity of cytosolic LC3B-I and LC3B-II in K-562 and
lymphoblastoid cell lines after 48 h of treatment, respectively.
The first difference observed between K-562 and
lymphoblastoid lines was the effect of YTX on cell viability.
Cellular proliferation is usually measured by MTT assay. This
assay informs about the percentage of viable cells capable to
reduce the MTT dye within the mitochondria (Mosmann, 1983;
Loveland et al., 1992; Verma et al., 2010). The quantification
of LDH release is a simple assay to know cell membrane
integrity, since after the lysis of the cells, LDH is released to the
extracellular medium and the released amount is proportional
to the number of broken cells (Lobner, 2000). In this regard,
the K-562 cell line did show a decrease in cell proliferation
accompanied by an increase in LDH release after both 24 and
48 h of YTX incubation. That is, after YTX treatment the number
of K-562 cells was decreasing because cell death was triggered,
since apoptosis and autophagy activation was observed, the
same as it was described in previous studies (Fernandez-Araujo
et al., 2014; Fernández-Araujo et al., 2015). However, in the
lymphoblastoid cell line, no effect in cell viability was observed
in the first 24 h of treatment, and after 48 h, cell proliferation
was decreased without any LDH release, that is without cellular
lysis. These results suggest no cell death activation but probably
proliferation arrested in the lymphoblastoid line after a long
term of YTX exposure. The decrease in the signal observed in
MTT assay in the lymphoblastoid line after 48 h YTX treatment
comparing with cells without treatment is due to a non-increase
in the cell number in the same way than the control where
the cells can proliferate. In addition at this time, an increase
in the mitochondrial mass, studied by flow cytometry, was
observed. In this sense, while the lymphoblastoid cell line
usually duplicate its population in 24 h (Sie et al., 2009), YTX
FIGURE 8 | Effect of YTX on cellular proliferation in K-562 and
lymphoblastoid cell lines. Cells were incubated with 30 nM YTX for 24 and
48 h (37◦C and 5% CO2 atmosphere). Cells were counted with the Scepter™
Handheld automated cell counter and confirmed as final concentration of
protein by Direct Detect™ and Bradford assay. (A) Number of K-562 cells
after 24 and 48 h of YTX incubation. (B) Number of lymphoblastoid cells after
24 and 48 h of YTX incubation. Mean ± SEM of four experiments. *Significant
differences between untreated and YTX-treated cells in each case by ANOVA
test.
could block this increase in the population without cell death
activation.
Interesting, the increase in caspase 8 activity was previously
observed in K-562 cell line after 24 h of YTX treatment
(Fernandez-Araujo et al., 2014). In the present paper, the
expression of the active form of caspase 8 is also observed in K-
562 cells. This active hallmark is typical from extrinsic apoptotic
pathway, and has never been discussed after YTX incubation
(Korsnes and Espenes, 2011; Korsnes, 2012; Fernandez-Araujo
et al., 2014). In addition, the levels of cytochrome c demonstrate
that YTX is also triggering the intrinsic apoptosis (Fulda and
Debatin, 2006). Therefore, YTX activates both intrinsic and
extrinsic apoptotic cell death. However, none of these hallmarks
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were observed in lymphoblastoid cells, showing different YTX
effects depending on the cellular model, as it was previously
pointed out (Tobío et al., 2012).
PDE4A is involved in the mechanism of action of YTX in
the K-562 cell line (Fernandez-Araujo et al., 2014). However,
after 24 h of YTX treatment, the levels of cytosolic PDE4A
were not modified in the lymphoblastoid cell line, and at this
time apoptotic hallmarks and cell viability were not modified
either. Moreover, when PDE4A was studied by western blot,
different molecular weights for both K-562 cell line and
lymphoblastoid cells were observed. This fact can be relevant
since any difference in the structure of the PDE4A protein
could be a key point of the mechanism of action of YTX. The
molecular structure of proteins is a critical parameter for the
affinity or interaction between proteins and other molecules,
as it was reported in previous studies (Funder et al., 1974;
Yatime et al., 2011; Tubaro et al., 2014). These differences can
lead to different YTX-PDE4A affinity or to different PDE4A
functions depending on the PDE4A structure. In this sense,
tumor cells have protein mutations that could lead to the
change in the protein function, and these mutations can be
used as tumor biomarkers (Wang et al., 2011). Therefore, the
PDE4A on the K-562 cell line seems to be the specific and
maybe a potential target to tumor therapies in this type of
leukemia.
After 48 h of YTX treatment, lymphoblastoid cells showed
similar features to those observed in the K-562 cell line
(cytosolic PDE4A and pmTOR decrease and LC3B-II/LC3B-I
ratio increase). However, these effects did not imply cell death
in the lymphoblastoid cell line, as LDH results have shown. At
this time, 48 h of YTX treatment, the autophagy activated in
K-562 leads to cell death. However, in the lymphoblastoid cell
line, autophagy pathway is activated, as the pmTOR and LC3B-
II/LC3B-I expression shows. Under unfavorable conditions cells
develop mechanisms to start the digestion or recycling of
different parts of the cell in order to obtain elements to survive
TABLE 1 | Summary of the viability, apoptotic and autophagic features of
K-562 and lymphoblastoid cell line after YTX incubation studied in this
paper.
Features K-562 tumor cell line Lymphoblastoid cell line





Cell death YES YES NO NO
Apoptotic hallmarks YES NO NO NO
Autophagic hallmarks NO YES NO YES
Number of cells
Apoptosis Autophagic No effect Cell proliferation
cell death cell death arrested
by autophagy
cell survive
under these critical conditions. Sometimes, the cell cannot
survive to this process, and autophagic cell death is activated
(Fulda, 2012). But in other times, the aim of the autophagy,
which is to survive in extreme conditions, is performed (Hu et al.,
2012). Contrary to the K-562 cell line, in lymphoblastoid cells,
although autophagy is activated, cell death is not induced while
a decrease in cell proliferation rate is observed. One possibility
could be the activation of the autophagic survival mechanism
through the cell growth regulator mTOR protein, the same as
it was described after nutrient deprivation in different type of
cells (Jung et al., 2010). A decrease in cell proliferation by
autophagic activation was also observed in colon cells and in
the human mammary epithelial cell line after treatment with
rapamycin and hydrogen sulfide, respectively (Wu et al., 2012;
Chen et al., 2013). Also, rapamycin has shown cell cycle arrest
in G1 phase of the mitosis in endometrial carcinomas (Bae-
Jump et al., 2010). Therefore, the activation of autophagy in the
lymphoblastoid cell line leads to a proliferation rate arrest due
to the YTX treatment. This theory is corroborated by the results
shown in Figure 8, since K-562 cells number is decreased by YTX
effect, while lymphoblastoid cells number is not modified after
YTX incubation, suggesting cellular proliferation arrest by the
toxin.
It was described that the point where cell proliferation,
apoptosis, and autophagy converge are the mitochondria
(Filippi-Chiela et al., 2011). Therefore, a close relationship
between MPTP and autophagy or apoptosis was established
(Lemasters et al., 1998). MPTP leads to mitochondrial membrane
depolarization that finally induces the opening transition pore to
release pro-apoptotic proteins to the cytosol (Weiss et al., 2003).
When the MPTP process is activated only in some mitochondria,
the autophagy is triggered, while apoptosis is activated when a
high number of mitochondria have MPTP activation (Lemasters
et al., 1998). But the exact linking mechanism between MPTP
and autophagy is unknown (Elmore et al., 2001). In his
work, after 48 h YTX treatment, when autophagic cell death is
activated in the K-562 line, mitochondrial mass was decreased.
In this context, mitophagy was defined as the mitochondrial
autophagy to describe the mitochondrial removal, characteristic
of autophagy activation (Youle and Narendra, 2011). On the
other hand, after the incubation with YTX for 48 h, the
mitochondrial mass was increased in the lymphoblastoid cell
line. Therefore, this is another hallmark to guarantee that the
autophagic process activated after 48 h in the K-562 cell line
is not occurring in the lymphoblastoid cell line. In the first
case, the cells activate autophagy accompanied by mitophagy
andmitochondrial signal decrease, while the lymphoblastoid cells
could activate autophagy as a survival process accompanied by an
increase of mitochondrial mass.
In conclusion, YTX modulates different pathways with
different final result depending on the cellular model. In the
tumor model, K-562 cells, the type II of programmed cell death
is triggered after YTX treatment. While in a non-tumor model,
the lymphoblastoid cell line, a survival autophagic process is
activated after toxin incubation. Furthermore, apoptosis is only
triggered in the tumor model, while in lymphoblastoid cell line,
this type of cell death was not activated after YTX incubation.
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This fact could be interesting in order to study the potential effect
of YTX in different anti-tumor therapeutics treatments. All these
results are summarized in Table 1.
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